Inventor · disambiguated record
Birgit Keil
Also filed as: KEIL BIRGIT
15 granted patents·19 pending applications·38 citations·filing 2006–2024
90Inventor score
Files withBAYER AG9GRUNENBERG ALFONS6ADVERIO PHARMA GMBH4BAYER SCHERING PHARMA AG3AICURIS GMBH & CO KG2
Top patents by PatentIndex Score
34 records- 0191US11203593B2Forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamateADVERIO PHARMA GMBH·Filed 2020·Granted Dec 21, 2021·2 cites·22 claims
- 0285US9637459B2Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agentsAICURIS GMBH & CO KG·Filed 2013·Granted May 2, 2017·4 cites·20 claims
- 0384US8466280B2Co-crystal compound of rivaroxaban and malonic acidGRUNENBERG ALFONS·Filed 2009·Granted Jun 18, 2013·18 cites·11 claims
- 0480US9340535B2N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrateAICURIS GMBH & CO KG·Filed 2012·Granted May 17, 2016·5 cites·25 claims
- 0579US12503469B2Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamateADVERIO PHARMA GMBH·Filed 2021·Granted Dec 23, 2025·0 cites·5 claims
- 0677US12202805B2Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compoundBAYER AG·Filed 2023·Granted Jan 21, 2025·0 cites·27 claims
- 0777US10087183B2Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamateADVERIO PHARMA GMBH·Filed 2017·Granted Oct 2, 2018·1 cites·30 claims
- 0877US8188270B2Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamideGRUNENBERG ALFONS·Filed 2006·Granted May 29, 2012·4 cites·5 claims
- 0972US12138256B2Treatment of cardiopulmonary disordersBAYER AG·Filed 2023·Granted Nov 12, 2024·0 cites·30 claims
- 1072US9957232B24-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide monohydrateGRUNENBERG ALFONS·Filed 2007·Granted May 1, 2018·2 cites·29 claims
- 1171US2025263381A1Process for preparing (5s)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4- yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compoundBAYER AG·Filed 2024·Application pending·0 cites
- 1269US10316001B2Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrilePH PHARMA CO LTD·Filed 2016·Granted Jun 11, 2019·1 cites·18 claims
- 1369US9926305B2SaltsBayer Pharma AG·Filed 2014·Granted Mar 27, 2018·1 cites·21 claims
- 1469US2025090519A1Treatment of cardiopulmonary disordersBAYER AG·Filed 2024·Application pending·0 cites
- 1566US10662188B2Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamateADVERIO PHARMA GMBH·Filed 2018·Granted May 26, 2020·0 cites·30 claims
- 1666US2025304566A1Crystalline forms of (5s)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2-chloro-4-methylbenzyl)-5,6-dihydro-4h-1,2,4-oxadiazineBAYER AG·Filed 2023·Application pending·0 cites
- 1763US10676443B2Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrilePH PHARMA CO LTD·Filed 2019·Granted Jun 9, 2020·0 cites·7 claims
- 1862US2015376184A1Forms of methyl methyl carbamateBAYER IP GMBH·Filed 2014·Application pending·0 cites
- 1960US2023104990A1Crystal forms of methyl(2r*,4r*)-4-[[(5s)-3-(3,5-difluorophenyl)-5-vinyl-4h-isoxazole-5-carbonyl]amino]tetrahydrofuran-2-carboxylate and their herbicidal synergistic effectsBAYER AG·Filed 2021·Application pending·0 cites
- 2056US2025281480A1Pharmaceutical dry powder inhalation formulationBAYER AG·Filed 2022·Application pending·0 cites
- 2156US2025282734A1Cholinate of 2-(1-cyclobutyl-1h-pyrazol-4-yl)-5-[([{1-[2-fluoro-4-(trifluoromethyl)-phenyl]cyclopropyl}carbonyl)amino]benzoic acidBAYER AG·Filed 2022·Application pending·0 cites
- 2255US2014315958A14-[4-(amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrateGRUENBERG ALFONS·Filed 2014·Application pending·0 cites
- 2349US2018194730A14-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrateBAYER IP GMBH·Filed 2018·Application pending·0 cites
- 2448US2011288174A1Monohydrate of 4-(phenyl)ethyl]-amino}methyl)benzoic acidGRUNENBERG ALFONS·Filed 2009·Application pending·0 cites
- 2548US2012010292A1Modification i of 4-(phenyl)ethyl]-amino}methyl)benzoic acidGRUNENBERG ALFONS·Filed 2009·Application pending·0 cites
- 2647US2011003829A1Enrofloxacin hexahydrateBAYER ANIMAL HEALTH GMBH·Filed 2008·Application pending·0 cites
- 2746US2010063112A1Polymorph iii of 4-[4-(amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamideBAYER SCHERING PHARMA AG·Filed 2007·Application pending·0 cites
- 2846US2010113533A1Polymorph II of 4-[4-(Amino)-3- Fluorophenoxy]-N-Methylpyridine-2-CarboxamideBAYER SCHERING PHARMA AG·Filed 2007·Application pending·0 cites
- 2942US2021261507A1Crystalline Form of FluopyramBAYER AG·Filed 2019·Application pending·0 cites
- 3037US2012316183A1Novel solvates of methylcarbamateGRUNENBERG ALFONS·Filed 2010·Application pending·0 cites
- 3137US2011183999A1Novel polymorphic forms of methyl carbamateBAYER SCHERING PHARMA AG·Filed 2010·Application pending·0 cites
- 3236US10336716B2Thermodynamically stable crystal modification of 2-methyl-N-(5-methyl-1, 3, 4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamideBAYER CROPSCIENCE AG·Filed 2016·Granted Jul 2, 2019·0 cites·11 claims
- 3336US2018208563A1Thermodynamically stable crystal modification of 2-chloro-3-(methylsulfanyl)-n-(1-methyl-1h-tetrazol-5-yl)-4-(trifluoromethyl)benzamideBAYER CROPSCIENCE AG·Filed 2016·Application pending·0 cites
- 3436US2018155336A1Process for the preparation of 2-{4-[2-({[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl}sulfanyl)-3,5-dicyan0-6-(pyrrolidin-1-yl)pyridin-4-yl]phenoxy}ethyl-l-alanyl-l-alaninate monohydrochlorideBayer Pharma AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Birgit Keil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →